Q3 2026 13F filing
Updated 6 days ago87 disclosed positions worth $468.1M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R REVOLUTION MEDICINES INC | $100M | 487.1K | 21.36% | — |
| 2 | A ATRICURE INC | $29.4M | 522.7K | 6.28% | — |
| 3 | C COMPASS PATHWAYS PLC | $26.6M | 2.14M | 5.68% | — |
| 4 | S SPDR S&P BIOTECH ETF | $23.9M | 151.5K | 5.10% | — |
| 5 | N NEKTAR THERAPEUTICS | $19.6M | 323.4K | 4.18% | — |
| 6 | I IDEAYA BIOSCIENCES INC | $16.9M | 438.7K | 3.60% | — |
| 7 | S STEREOTAXIS INC | $16.8M | 13.68M | 3.60% | — |
| 8 | D DENALI THERAPEUTICS INC | $15.4M | 744.0K | 3.29% | — |
| 9 | A ASCENDIS PHARMA A/S | $11.4M | 50.0K | 2.43% | — |
| 10 | R ARCUS BIOSCIENCES INC | $11.4M | 439.8K | 2.43% | — |
| 11 | C CYTOKINETICS INC | $11.3M | 172.0K | 2.42% | — |
| 12 | E EDGEWISE THERAPEUTICS INC | $9M | 221.8K | 1.92% | — |
| 13 | N NEUROCRINE BIOSCIENCES INC | $8.9M | 62.7K | 1.90% | — |
| 14 | P INSULET CORP | $8.9M | 67.9K | 1.89% | — |
| 15 | X XENON PHARMACEUTICALS INC | $7.6M | 204.8K | 1.63% | — |
| 16 | A AXOGEN INC | $7.5M | 180.0K | 1.61% | — |
| 17 | D DEXCOM INC | $7.4M | 86.3K | 1.59% | — |
| 18 | S SYNDAX PHARMACEUTICALS INC | $6.2M | 331.3K | 1.33% | — |
| 19 | L LARIMAR THERAPEUTICS INC | $6M | 1.89M | 1.29% | — |
| 20 | T TANDEM DIABETES CARE INC | $5.8M | 355.2K | 1.24% | — |
| 21 | B BICARA THERAPEUTICS INC | $5.6M | 300.0K | 1.19% | — |
| 22 | R RAPPORT THERAPEUTICS INC | $4.8M | 141.9K | 1.02% | — |
| 23 | I IMMUNOVANT INC | $4.6M | 135.5K | 0.98% | — |
| 24 | I INOGEN INC | $4.5M | 845.2K | 0.95% | — |
| 25 | N NEUROGENE INC | $4.2M | 150.5K | 0.89% | — |
| 26 | A ALKERMES PLC | $4.1M | 101.3K | 0.88% | — |
| 27 | C CENTURY THERAPEUTICS INC | $4.1M | 2.39M | 0.87% | — |
| 28 | K ORTHOPEDIATRICS CORP | $4M | 179.1K | 0.85% | — |
| 29 | G LAKEFRONT BIOTHERAPEUTICS NV | $3.9M | 130.2K | 0.82% | — |
| 30 | S STOKE THERAPEUTICS INC | $3.8M | 146.1K | 0.81% | — |
| 31 | A ADLAI NORTYE GROUP LTD | $3.7M | 232.8K | 0.80% | — |
| 32 | E EUPRAXIA PHARMACEUTICALS INC | $3.7M | 404.6K | 0.79% | — |
| 33 | C CELLDEX THERAPEUTICS INC NEW | $3.5M | 108.1K | 0.75% | — |
| 34 | A ALLOGENE THERAPEUTICS INC | $3.2M | 2.00M | 0.68% | — |
| 35 | B BIOCRYST PHARMACEUTICALS INC | $3.2M | 380.2K | 0.68% | — |
| 36 | K KYMERA THERAPEUTICS INC | $3M | 26.9K | 0.64% | — |
| 37 | A AQUESTIVE THERAPEUTICS INC | $3M | 640.9K | 0.63% | — |
| 38 | R ATRIUM THERAPEUTICS INC | $2.5M | 300.1K | 0.53% | — |
| 39 | E ISHARES NASDAQ BIOTECH INDX | $2.4M | 11.6K | 0.52% | — |
| 40 | P PROCEPT BIOROBOTICS CORP | $2.2M | 120.0K | 0.47% | — |
| 41 | P PROQR THERAPEUTICS NV | $2.2M | 1.31M | 0.47% | — |
| 42 | H CYBIN INC | $2.2M | 175.7K | 0.46% | — |
| 43 | A ALIGN TECHNOLOGY INC | $2M | 14.0K | 0.43% | — |
| 44 | V VIKING THERAPEUTICS INC | $1.8M | 54.5K | 0.38% | — |
| 45 | M MAZE THERAPEUTICS INC | $1.8M | 65.0K | 0.38% | — |
| 46 | A ALECTOR INC | $1.7M | 908.4K | 0.36% | — |
| 47 | ? N/A TELA BIO INC | $1.7M | 1.44M | 0.35% | — |
| 48 | M MAPLIGHT THERAPEUTICS INC | $1.6M | 155.6K | 0.34% | — |
| 49 | N NERVGEN PHARMA CORP | $1.5M | 810.9K | 0.33% | — |
| 50 | G STRUCTURE THERAPEUTICS INC | $1.5M | 46.5K | 0.31% | — |